CD274 and neoplasm: For example, the Checkmate 143 clinical trial indicated that the expression of PD-L1 on tumour cells does not correlate with the efficacy of immunotherapy, which might be due to the difficulties with PD-L1 detection methods and tumour heterogeneity.